The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov

The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov

Abstract Background Well-designed clinical trials are of great importance in validating novel treatments and ensuring an evidence-based approach for sarcoma. This study aimed to provide a comprehensive landscape of the characteristics of metastatic or advanced sarcoma clinical trials using the subst...

Full description

Bibliographic Details
Main Authors: Y Que, W Xiao, BS Xu, XZ Wen, DS Weng, X Zhang
Format: Article
Language:English
Published: BMC 2018-12-01
Series:BMC Cancer
Subjects:
Sarcoma
ClinicalTrials.gov
Target therapy
Immunotherapy
Landscape
Online Access:http://link.springer.com/article/10.1186/s12885-018-5163-2

Internet

http://link.springer.com/article/10.1186/s12885-018-5163-2

Similar Items